Asthma, Bronchial Clinical Trial
Official title:
A Non-interventional, Prospective Study With Benralizumab to Investigate Clinical Outcome Based on Standard of Care Medication in Real-life
This is a prospective, non-interventional, single-arm, multicenter study to investigate asthma control, and health-related quality of life (HRQL), lung function and asthma medication intake in severe eosinophilic asthma patients treated with benralizumab in a real-life setting in Germany.
This is a prospective observational study to investigate the asthma control and health realted quality of life (HRQL) of benralizumab treated patients in routine clinical practice, their asthma medication intake, and their changes in asthma medication during the study, up to 52 weeks. The asthma control will be analyzed by using the Asthma Control Test (ACT) and the Asthma Impairment and Risk Questionnaire (AIRQ®) at different timepoints during the study period either collected by the investigator or self-reported by the patient. In addition, health realted quality of life will be assessed at baseline and routine follow-up visits using the mini Asthma Quality of Life Questionnaire (miniAQLQ) which is collected by the investigator. To investigate the medication intake and assess the changes in asthma medication, the patients will record their weekly medication intake in a paper-based or an electronic medication diary throughout the study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00825903 -
The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population
|
N/A | |
| Completed |
NCT00734318 -
Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma
|
Phase 3 | |
| Terminated |
NCT00385593 -
Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
|
Phase 3 | |
| Completed |
NCT00213252 -
Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
|
Phase 2 | |
| Completed |
NCT00092092 -
Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)
|
Phase 4 | |
| Completed |
NCT00489346 -
A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)
|
Phase 3 | |
| Withdrawn |
NCT03989635 -
Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.
|
Phase 2 | |
| Withdrawn |
NCT00540839 -
A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
|
Phase 3 | |
| Recruiting |
NCT06299306 -
REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma
|
||
| Recruiting |
NCT00312312 -
Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide
|
N/A | |
| Completed |
NCT00092885 -
An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
|
Phase 3 | |
| Completed |
NCT02805907 -
Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)
|
Phase 4 | |
| Not yet recruiting |
NCT00644462 -
Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording
|
N/A | |
| Completed |
NCT03839433 -
The Mannitol-Asthma-Ciclesonide-Study
|
Phase 4 | |
| Completed |
NCT00640120 -
Wheeze Detection in Children During Dynamic Bronchial Situations Measured by WIM-PC™ Recording
|
N/A | |
| Recruiting |
NCT05937334 -
The Cohort Study for Asthma in China
|
||
| Completed |
NCT03034447 -
Sleep Apnea in Asthmatic Children and Teenagers
|
N/A | |
| Completed |
NCT05270278 -
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
|
||
| Withdrawn |
NCT00830427 -
A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects
|
Phase 2 | |
| Completed |
NCT00092105 -
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
|
Phase 3 |